Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSXY
976
Victoria's Secret
VSXY
$7.39B
| $10.7M | 0.02% |
259,200
-501,000
| -66% | -$17.7M |
|
977
CEMIG Preferred Shares
CIG
$5.58B
| $10.7M | 0.02% |
6,058,298
-528,951
| -8% | -$1.03M |
|
978
California Resources
CRC
$4.69B
| $10.7M | 0.02% |
206,636
+152,100
| +279% | +$8.26M |
|
979
Ultragenyx Pharmaceutical
RARE
$2.6B
| $10.7M | 0.02% |
254,700
+72,600
| +40% | +$3.6M |
|
980
Delek US
DK
$4.12B
| $10.6M | 0.02% |
570,469
-146,500
| -20% | -$2.62M |
|
981
Merit Medical Systems
MMSI
$5.45B
| $10.5M | 0.02% |
108,712
+15,400
| +17% | +$1.53M |
|
982
Western Union
WU
$2.34B
| $10.5M | 0.02% |
991,900
+411,500
| +71% | +$4.56M |
|
983
Cadre Holdings
CDRE
$1.44B
| $10.5M | 0.02% |
324,400
+1,600
| +0.5% | +$56.9K |
|
984
Americold
COLD
$4.17B
| $10.5M | 0.02% |
489,413
-596,187
| -55% | -$14.4M |
|
985
Western New England Bancorp
WNEB
$282M
| $10.4M | 0.02% |
1,133,162
-38,100
| -3% | -$343K |
|
986
Otis Worldwide
OTIS
$28.2B
| $10.4M | 0.02% |
+112,400
| New | +$11.3M |
|
987
Navigator Holdings
NVGS
$1.26B
| $10.4M | 0.02% |
675,288
-76,100
| -10% | -$1.2M |
|
|
AMWD
988
DELISTED
American Woodmark
AMWD
| $10.3M | 0.02% |
130,101
+52,800
| +68% | +$4.83M |
|
989
iShares National Muni Bond ETF
MUB
$45.9B
| $10.3M | 0.02% |
97,030
-205,570
| -68% | -$22.1M |
|
990
Idexx Laboratories
IDXX
$44.7B
| $10.3M | 0.02% |
25,000
-10,700
| -30% | -$4.69M |
|
991
Aramark
ARMK
$16.1B
| $10.3M | 0.02% |
+276,700
| New | +$10.8M |
|
992
Blue Bird Corp
BLBD
$2.04B
| $10.3M | 0.02% |
266,462
-215,659
| -45% | -$9.01M |
|
993
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$41.9B
| $10.3M | 0.02% |
+182,300
| New | +$10.2M |
|
994
Jack Henry & Associates
JKHY
$10.8B
| $10.3M | 0.02% |
58,519
+40,000
| +216% | +$7.15M |
|
995
Futu Holdings
FUTU
$14.7B
| $10.2M | 0.02% |
127,926
-224,286
| -64% | -$21M |
|
996
StoneX
SNEX
$8.05B
| $10.2M | 0.02% |
352,499
+86,063
| +32% | +$2.41M |
|
997
Winnebago Industries
WGO
$915M
| $10.2M | 0.02% |
214,000
+143,800
| +205% | +$8.15M |
|
998
Procore
PCOR
$9.45B
| $10.2M | 0.02% |
136,300
+2,500
| +2% | +$177K |
|
999
CVR Energy
CVI
$3.52B
| $10.2M | 0.02% |
544,693
+110,460
| +25% | +$2.23M |
|
1000
Vanguard Morningstar Mid-Cap ETF
VO
$111B
| $10.2M | 0.02% |
154,400
+142,000
| +1,145% | +$9.64M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.